UNSPSC 51422120: Mometasone furoate

This classification denotes a therapeutic glucocorticoid with the molecular formula C27H30Cl2O6, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 04201GDN4R, chemically known as 9,21-dichloro-11beta,17-dihydroxy-16alpha-methylpregna-1,4-diene-3,20-dione 17-(2-furoate) but more generally known as mometasone furoate, which bears US NIH Compound Identifier 55188. European Medicines Agency schedules Mometasone furoate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB03318MIG.

UNSPSC 51422120 Mometasone furoate is a Commodity code that describes a corticosteroid pharmaceutical product, but the recent state and local procurement activity tagged under this code shows a significant mismatch: the one recorded opportunity solicits naloxone and drug deactivation systems for community health support, not mometasone. State and local governments classified this naloxone procurement under the mometasone code, suggesting either a cataloging error or a broader pharmaceutical commodity grouping in use at the issuing body. The actual work being bought under this code classification includes emergency opioid-reversal medication and associated deactivation systems for public health agencies, delivered through competitive bidding with compliance requirements typical of government procurement.

Seminole County, Florida posted the recorded opportunity (IFB 60459723LAS) on June 30, 2026, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually through an invitation for bid process with a response deadline of July 26, 2023. Quarterly deliveries were required to the Seminole County Community Health Building in Sanford, with vendors responsible for all shipping and delivery costs. Bidders had to comply with E-Verify requirements, drug-free workplace certification, and maintain workers' compensation and general liability insurance; the contract included a three-month probationary period and was potentially funded through FEMA, introducing additional federal compliance obligations. This appears to be the only recent solicitation activity under this code, limiting visibility into broader geographic patterns or repeat-buyer activity in the state and local mometasone or naloxone market.